Table 2.
NIRS and SpO2 measurements
| noPDA (n = 64) Mean (SD) |
PDA (n = 41) Mean (SD) |
HsPDA (n = 18) Mean (SD) |
P value | |
|---|---|---|---|---|
| Cerebral rSpO22, 3 | 79.3 (2.45) | 79.7 (2.27) | 77.0 (5.16) | 0.004 |
| Renal rSpO21, 2 | 76.7 (7.64) | 71.7 (9.02) | 67.4 (13.48) | < 0.001 |
| SpO22, 3 | 93.8 (1.88) | 93.7 (1.62) | 91.7 (2.70) | 0.001 |
| Cerebral FTOE | 0.15 (0.033) | 0.15 (0.026) | 0.16 (0.047) | 0.566 |
| Renal FTOE1, 2 | 0.18 (0.079) | 0.23 (0.092) | 0.24 (0.117) | 0.002 |
1: Statistically significant difference between the “noPDA” and “PDA” groups
2: Statistically significant difference between the “noPDA” and “HsPDA” groups
3: Statistically significant difference between the “PDA” and “HsPDA” groups